News
NEWS
-
R&DTokyo Medical and Dental University and Celaid Therapeutics Inc. Joint Research Agreement on Research and Development of Gene-modified Cell Thera…
-
newsCelaid Therapeutics Inc has been selected for the Silicon Valley Immersion Program sponsored by NEDO
-
newsSpeaker at Biopharmaceutical EXPO
-
financing
Celaid has raised 1.2 billion yen in its Series A financing round to advance HSC-based cell and gene therapies and platform
-
R&D
FBRI and Celaid have executed a collaborative research agreement for vascular regeneration products derived from human hematopoietic stem cells
-
R&D
Chosen for the New Energy and Industrial Technology Development Organization (NEDO) Deep Tech Startup Support Project (DTSU)
-
newsPresentation at the "OUVC Innovators' Meeting"
-
newsSpeaker at a symposium sponsored by MHLW
- 1
- 2